Literature DB >> 8442401

Cognitive performance in HIV-1 infection: relationship to severity of disease and brain atrophy.

E Poutiainen1, I Elovaara, R Raininko, L Hokkanen, S L Valle, J Lähdevirta, M Iivanainen.   

Abstract

We examined cognitive performance in 72 HIV-1 infected patients and 34 controls. None of the patients had opportunistic infections or unusual neoplasms of the central nervous system (CNS). Factors other than HIV-1 known to cause cognitive decline were excluded from both groups. Cognitive functioning analysed with special emphasis on the severity of HIV infection was related to neuroradiological and immunological findings. In patients with AIDS-related complex (CDC IVa) or AIDS (CDC IVc,d), a deterioration of memory as well as cognitive speed and flexibility was detected. Furthermore, memory deficits were associated with central cerebral and infratentorial atrophy in those patients, while no association was found between cognitive deficits and immunological abnormalities. Patients at CDC stages II or III showed slight association between altered cognitive speed and flexibility and elevated leukocyte count, suggesting a subclinical CNS disease already at early stages of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8442401     DOI: 10.1111/j.1600-0404.1993.tb04083.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

Review 1.  Recent advances in the neurology of HIV infection.

Authors:  R K Petty
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

2.  Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance.

Authors:  Johannes C Rothlind; Tanya M Greenfield; Anne V Bruce; Dieter J Meyerhoff; Derek L Flenniken; Joselyn A Lindgren; Michael W Weiner
Journal:  J Int Neuropsychol Soc       Date:  2005-01       Impact factor: 2.892

3.  Correlation between percentage of brain parenchymal volume and neurocognitive performance in HIV-infected patients.

Authors:  Sohil H Patel; Dennis L Kolson; Guila Glosser; Isabel Matozzo; Yulin Ge; James S Babb; Lois J Mannon; Robert I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2002-04       Impact factor: 3.825

4.  Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era.

Authors:  Anika Guha; Matthew R Brier; Mario Ortega; Elizabeth Westerhaus; Brittany Nelson; Beau M Ances
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-01       Impact factor: 3.731

5.  HIV-specific changes in the motor performance of HIV-positive intravenous drug abusers.

Authors:  H J von Giesen; H Hefter; H Roick; S Mauss; G Arendt
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

Review 6.  Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation.

Authors:  J L Cadet; I N Krasnova
Journal:  Neurotox Res       Date:  2007-10       Impact factor: 3.911

7.  Three-decade neurological and neurocognitive follow-up of HIV-1-infected patients on best-available antiretroviral therapy in Finland.

Authors:  T Heikinheimo; E Poutiainen; O Salonen; I Elovaara; M Ristola
Journal:  BMJ Open       Date:  2015-11-05       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.